INSM ▼ -1.8% - Insmed Incorporated
$INSM INSM - Insmed Features the Global Phase 3 PALM Clinical Development Program Evaluating Treprostinil Palmitil Inhalation Powder (TPIP) at CHEST 2026
15-OCT-2026 07:00 AM ET
Share this post
More filings for $INSM
INSM ▼ -0.1% - Insmed IncorporatedOct 14, 2026INSM ▼ -4.6% - Insmed IncorporatedOct 5, 2026INSM ▼ -4.6% - Insmed IncorporatedOct 5, 2026INSM ▲ +4.5% - Insmed IncorporatedSep 21, 2026INSM ▲ +0.4% - Insmed IncorporatedSep 16, 2026INSM ▼ -1.1% - Insmed IncorporatedSep 4, 2026
View full $INSM filing history →💬 Comments
Loading comments…
Leave a comment